Health · 1 sources covering this

STAT+: Trump’s drug-pricing deals set to be tested by new product launches

The public is about to get its first look at the prices of drugs launched since President Trump struck his most-favored-nation deals with 17 drugmakers.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Trump’s drug-pricing deals set to be tested by new product launches
The public is about to get its first look at the prices of drugs launched since President Trump struck his most-favored-nation deals with 17 drugmakers.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/e06a5a45f366ae52ab9af18eade1675d0d3abb43"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Trump’s drug-pricing deals set to be tested by new product launches"></iframe>

STAT+: Trump’s drug-pricing deals set to be tested by new product launches

How 1 sources are covering this

STAT+: Trump’s drug-pricing deals set to be tested by new product launches

More from Health

In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles

Listen to the Latest ‘KFF Health News Minute’

American Cancer Society says adults should start colorectal cancer screenings at 45

STAT+: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

Reader

Trust & legal

Across the network